Clinical Trials in Dermatology and Oncology

A modern drug is built on clinical preliminary. Progress in medicine and dermatology depends on randomized, double-blinded, fake treatment controlled studies. The most well-known medical disorders in the United States are skin conditions including psoriasis and atopic dermatitis. Clinical preliminaries that can provide a drug not only offer target improvements in clinical sickness status but also abstract improvements in the patients' quality of life for those who are suffering from the disease

  • Mastocytosis
  • Immunotherapy Agents
  • Non-melanoma Skin Cancers
  • Autoimmune blistering diseases

Related Conference of Clinical Trials in Dermatology and Oncology

February 01-02, 2024

37th World Congress on Pharmacology

Dubai, UAE
February 22-23, 2024

34th Annual European Pharma Congress

Zurich, Switzerland
April 04-05, 2024

17th European Biosimilars Congress

Madrid, Spain
April 11-12, 2024

5th Annual Congress on Antibiotics and Bacterial Infections

Amsterdam, Netherlands
May 09-10, 2024

4th Global Summit on Pharmaceutical Research

Barcelona, Spain
May 16-17, 2024

18th World Drug Delivery Summit

Rome, Italy
May 30-31, 2024

9th Pharmaceutical Chemistry Conference

Paris, France
September 11-12, 2024

9th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
September 25-26, 2024

4th World Congress on Rare Diseases & Orphan Drugs

Paris, France

Clinical Trials in Dermatology and Oncology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in